Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) (340174)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Deadline: The deadline for this grant has passed

Grant amount: Up to US $450,000

Funding uses: Research

Location of project: Preferred: United States Other eligible locations: Anywhere in the world

Location of residency: Preferred: United States Other eligible locations: Anywhere in the world

Overview:

The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological drug abuse treatment interventions, including interventions for patients with comorbidities;

• drug abuse treatment and adherence interventions;
• drug abuse treatment and adherence interventions that utilize technologies to boost effects and increase implementability and sustainability;
• interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment;
• interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and 
• interventions to treat substance misuse and chronic pain.

Research of interest includes but is not limited to Stage I research.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.